Ncardia Launches First iPSC-Derived Non-Human Primate Cardiomyocytes for Translational Cardiac Research

-Ncardia, a leader in stem cell–based solutions for drug discovery and safety assessment,  announced the launch of Ncyte® NHP-C vCardiomyo...

September 24, 2025 | Wednesday | News
Sartorius Opens GMP Facility in Illkirch to Boost Cell and Gene Therapy Production

New GMP facility for transfection reagents of French sub-group Sartorius Stedim Biotech in Illkirch Facility equipped to support next-generation techn...

September 19, 2025 | Friday | News
Greenwich LifeSciences Expands Phase III FLAMINGO-01 Breast Cancer Trial to Ireland

Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO...

September 19, 2025 | Friday | News
Merck Opens Climate-Neutral Life Science Facility in Blarney to Strengthen Global Biopharma Supply

Merck, a leading science and technology company,  announced the official opening of its new Life Science manufacturing facility in Blarney, Ireland....

September 19, 2025 | Friday | News
Ono Pharmaceutical and Deciphera Secure European Commission Approval for Vimseltinib (ROMVIMZA™) as First Therapy for TGCT in the EU

Vimseltinib is the first and only therapy with marketing authorization for the treatment of TGCT in the European Union Ono Pharmaceutical Co.,...

September 18, 2025 | Thursday | News
AccuStem Sciences and EmeritusDX Expand Blood-Based Cancer Testing Capabilities with Advanced miRNA Platform

AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with or at risk of cancer, annou...

September 18, 2025 | Thursday | News
Sanofi’s Brivekimig Demonstrates Positive Phase 2a Results in Moderate-to-Severe Hidradenitis Suppurativa

In phase 2a study, brivekimig led to clinically meaningful improvements in primary and key secondary endpoints in biologic-naïve patients compared...

September 18, 2025 | Thursday | News
Cenevo Launches Labguru Assistant to Bring AI-Driven Support Directly Into Scientists’ Daily Work

Cenevo is launching the Labguru Assistant, an AI-enabled extension to the Labguru solution designed to provide scientists with real-time, in-platform suppo...

September 18, 2025 | Thursday | News
Celltrion Pharm Signs Strategic Trilateral Agreement with BD to Boost Global Prefilled Syringe CMO Business

-Celltrion Pharm , a South Korean biopharmaceutical firm, said on September 16 that it has inked a strategic trilateral agreement with a multination...

September 17, 2025 | Wednesday | News
Galimedix Completes Phase 1 Trial of Oral GAL-101, Advancing Toward Phase 2 in Alzheimer’s Disease

GAL-101 was well tolerated; excellent safety and pharmacokinetic profile strongly support oral administration GAL-101 effectively crosses the blood-br...

September 15, 2025 | Monday | News
Belite Bio Completes Phase 3 DRAGON Trial of Tinlarebant in Stargardt Disease

Tinlarebant has been granted Breakthrough Therapy, Fast Track, and Rare Pediatric Disease Designations in the U.S.; Orphan Drug Designation in the U.S....

September 15, 2025 | Monday | News
AVITA Medical Secures CE Mark for RECELL® GO, Expanding European Access to Innovative Burn Care

- AVITA Medical, Inc., a leading therapeutic acute wound care company,announced it has received the CE Mark under the European Union Medical Device Regul...

September 15, 2025 | Monday | News
Pioneering DNA Innovator Dr. Martin Schleef Wins NRW Innovation Award 2025

The founder and long-standing CEO of PlasmidFactory GmbH, Dr. Martin Schleef, was honored in Düsseldorf with the Innovation Award 2025 of the State ...

September 11, 2025 | Thursday | News
QIAGEN Secures CE-IVDR Certification for Full QIAstat-Dx Portfolio, Expands Syndromic Testing Panels

Full portfolio of QIAstat-Dx panels now CE-IVDR certified for use in clinical syndromic testing, underscoring commitment to highest-quality diagnosti...

September 11, 2025 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close